On Thursday 07/18/2024 the closing price of the Ceridian HCM Holding Inc Registered Shs share was $53.22 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $53.27, this is a drop of 0.09%.
Ceridian HCM Holding Inc Registered Shs's market capitalization is $8.43 B by 157.90 M shares outstanding.
Is Ceridian HCM stock a Buy, Sell or Hold?
Ceridian HCM stock has received a consensus rating of buy. The average rating score is and is based on 24 buy ratings, 23 hold ratings, and 1 sell ratings.What was the 52-week low for Ceridian HCM stock?
The low in the last 52 weeks of Ceridian HCM stock was 47.10. According to the current price, Ceridian HCM is 113.25% away from the 52-week low.What was the 52-week high for Ceridian HCM stock?
The high in the last 52 weeks of Ceridian HCM stock was 75.47. According to the current price, Ceridian HCM is 70.68% away from the 52-week high.What are analysts forecasts for Ceridian HCM stock?
The 48 analysts offering price forecasts for Ceridian HCM have a median target of 75.17, with a high estimate of 105.00 and a low estimate of 52.00. The median estimate represents a 70.96 difference from the last price of 53.34.Ceridian HCM Stock Snapshot
45.00
Bid
10.00
Bid Size
57.21
Ask
100.00
Ask Size
7/19/2024
Date
3:59 PM
Time
0.00
Volume
53.22
Prev. Close
0.00
Open
157.90 M
Number of Shares
47.10
52 Week Low
75.47
52 Week High
53.34
0.00
Dividend in USD
0.00
Dividend Yield
194.16
P/E Ratio
98.19
Free Float in %
0.35
EPS in USD
15.34
Book Value per Share in USD
1.38
Cash Flow per Share in USD
Ceridian HCM News More News
Historical Prices for Ceridian HCM
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Ceridian HCM Analyst Data
Total Analysts: 50
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 48.00
Median: 74.16
Highest: 105.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Ceridian HCM Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
07/02/24 | Piper Sandler | Maintained Hold | $68 | |||
06/21/24 | Wells Fargo & Co | Maintained Hold | $52 | |||
06/18/24 | Citigroup Corp. | Maintained Buy | $66 | |||
06/11/24 | BMO Capital Markets | Maintained Buy | $75 | |||
05/16/24 | Piper Sandler | Maintained Hold | $68 | |||
05/06/24 | BMO Capital Markets | Maintained Buy | $75 | |||
05/06/24 | Mizuho | Maintained Buy | $80 | |||
05/02/24 | Barclays Capital | Maintained Hold | $62 | |||
05/02/24 | Piper Sandler | Maintained Hold | $68 | |||
05/02/24 | Needham & Company, LLC | Maintained Buy | $82 | |||
02/12/24 | Needham & Company, LLC | Maintained Buy | $82 | |||
02/08/24 | Barclays Capital | Maintained Hold | $74 | |||
02/08/24 | Needham & Company, LLC | Maintained Buy | $82 | |||
02/08/24 | Piper Sandler | Maintained Hold | $75 | |||
01/19/24 | Baird Patrick & Co | Maintained Buy | $86 | |||
01/10/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $75 | |||
12/05/23 | Needham & Company, LLC | Maintained Buy | $82 | |||
11/07/23 | UBS | Maintained Buy | $87 | |||
11/02/23 | J.P. Morgan | Maintained Hold | $62 | |||
11/02/23 | Needham & Company, LLC | Maintained Buy | $82 | |||
10/23/23 | Goldman Sachs | Maintained Hold | $74 | |||
10/12/23 | Piper Sandler | Maintained Hold | $73 | |||
10/05/23 | Needham & Company, LLC | Upgraded to Buy | $82 | |||
08/03/23 | Barclays Capital | Maintained Hold | $74 | |||
08/03/23 | Piper Sandler | Maintained Hold | $73 | |||
07/21/23 | Citigroup Corp. | Maintained Buy | $84 | |||
05/04/23 | Credit Suisse | Maintained Buy | $83 | |||
05/04/23 | Wells Fargo & Co | Maintained Hold | $65 | |||
05/04/23 | Barclays Capital | Maintained Hold | $73 | |||
05/04/23 | Piper Sandler | Maintained Hold | $70 | |||
04/28/23 | Piper Sandler | Maintained Hold | $78 | |||
02/10/23 | Baird Patrick & Co | Maintained Buy | $86 | |||
02/09/23 | Cowen and Company, LLC | Maintained Buy | $87 | |||
02/09/23 | BMO Capital Markets | Maintained Buy | $86 | |||
02/09/23 | Wells Fargo & Co | Maintained Hold | $75 | |||
02/09/23 | Credit Suisse | Maintained Buy | $105 | |||
02/09/23 | Mizuho | Maintained Buy | $95 | |||
02/09/23 | Barclays Capital | Maintained Hold | $74 | |||
02/09/23 | Piper Sandler | Maintained Hold | $78 | |||
01/10/23 | Barclays Capital | Maintained Hold | $64 | |||
11/14/22 | Cowen and Company, LLC | Maintained Buy | $77 | |||
11/03/22 | J.P. Morgan | Maintained Hold | $70 | |||
10/31/22 | Barclays Capital | Upgraded to Hold | $64 | |||
10/18/22 | Barclays Capital | Maintained Sell | $54 | |||
09/01/22 | Citigroup Corp. | Maintained Buy | $73 | |||
08/04/22 | BMO Capital Markets | Maintained Buy | $73 | |||
08/04/22 | Credit Suisse | Maintained Buy | $75 | |||
08/04/22 | Piper Sandler | Maintained Hold | $60 |
Ceridian HCM Estimates* in USD
2024 | 2025 | 2026 | 2027 | |
---|---|---|---|---|
Revenue | 1,735 | 1,970 | 2,252 | - |
Dividend | 0.00 | 0.00 | 0.00 | - |
Dividend Yield (in %) | 0.00 % | 0.00 % | 0.00 % | - |
EPS | 1.63 | 2.02 | 2.45 | 3.24 |
P/E Ratio | 32.76 | 26.46 | 21.74 | 16.46 |
EBIT | 395 | 475 | 590 | - |
EBITDA | 494 | 587 | 717 | - |
Net Profit | 69 | 159 | 343 | - |
Net Profit Adjusted | 263 | 330 | 411 | - |
Pre-Tax Profit | 347 | 423 | 541 | - |
Net Profit (Adjusted) | 119 | 223 | 366 | - |
EPS (Non-GAAP) ex. SOE | 1.63 | 2.02 | 2.45 | 3.24 |
EPS (GAAP) | 0.41 | 0.94 | 1.73 | - |
Gross Income | 865 | 1,007 | 1,330 | - |
Cash Flow from Investing | 1,796 | 21 | - | - |
Cash Flow from Operations | 295 | 345 | - | - |
Cash Flow from Financing | 1,796 | 21 | - | - |
Cash Flow per Share | 1.66 | 1.99 | 2.95 | - |
Free Cash Flow | 186 | 229 | 273 | - |
Free Cash Flow per Share | 0.90 | 1.20 | - | - |
Book Value per Share | 16.03 | 17.17 | 20.62 | - |
Net Debt | 690 | 479 | 195 | - |
Research & Development Exp. | 195 | 221 | 259 | - |
Capital Expenditure | 17 | 20 | 23 | - |
Selling, General & Admin. Exp. | 522 | 596 | 607 | - |
Shareholder’s Equity | 2,634 | 2,950 | 3,371 | - |
Total Assets | 9,721 | 10,128 | - | - |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 16 | 16 | 16 | 16 | 16 |
Average Estimate | 0.363 USD | 0.414 USD | 0.428 USD | 1.628 USD | 2.016 USD |
Year Ago | 0.020 USD | -0.024 USD | 0.292 USD | 0.353 USD | - |
Publish Date | 7/31/2024 | 10/30/2024 | 2/5/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | 16 | 16 | 16 | 16 | 16 |
Average Estimate | 418 USD | 431 USD | 455 USD | 1,735 USD | 1,970 USD |
Year Ago | 366 USD | 378 USD | 400 USD | 1,514 USD | - |
Publish Date | 7/31/2024 | 10/30/2024 | 2/5/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 1,513.70 | 1,246.20 | 1,024.20 | 842.50 | 824.10 | 746.40 | 750.70 |
Change of sales in % | 21.47 | 21.68 | 21.57 | 2.23 | 10.41 | -0.57 | 6.60 |
Gross profit on sales | 790.70 | 636.50 | 492.50 | 417.90 | 418.10 | 357.30 | 317.40 |
Gross profit on sales change in % | 24.23 | 29.24 | 17.85 | -0.05 | 17.02 | 12.57 | 15.50 |
Operating income | 142.10 | 20.20 | -28.10 | 25.60 | 78.50 | 49.90 | 40.00 |
Operating income change in % | 603.47 | - | - | -67.39 | 57.31 | 24.75 | 1,150.00 |
Income before tax | 96.00 | -62.90 | -90.30 | -20.00 | 34.30 | -30.40 | -54.50 |
Income before tax change in % | - | 30.34 | -351.50 | - | - | 44.22 | 40.44 |
Income after tax | 54.80 | -73.40 | -75.40 | -4.00 | 78.70 | -63.40 | -8.50 |
Income after tax change in % | - | 2.65 | -1,785.00 | - | - | -645.88 | 92.90 |
Balance Sheet in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 6,612.70 | 5,807.80 | 4,938.70 | 4,603.10 | 4,203.40 | 3,622.40 | 5,600.90 |
Long-term liabilities per share | 8.18 | 8.28 | 7.87 | 4.98 | 5.76 | 6.16 | 9.62 |
Equity | 2,398.20 | 2,109.40 | 2,227.50 | 2,098.20 | 1,882.30 | 1,532.00 | 1,129.00 |
Equity change in % | 13.69 | -5.30 | 6.16 | 11.47 | 22.87 | 69.13 | 1.75 |
Balance sheet total | 9,010.90 | 7,917.20 | 7,166.20 | 6,701.30 | 6,085.70 | 5,154.40 | 6,729.90 |
Balance sheet total change in % | 13.81 | 10.48 | 6.94 | 10.12 | 18.07 | -23.41 | 5.13 |
Key Data in USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 9.55 | 8.15 | 6.81 | 5.74 | 5.54 | 6.54 | 5.44 |
P/E ratio (year end quote, basic EPS) | 194.16 | - | - | - | 128.32 | - | - |
P/E ratio (year end quote, diluted EPS) | 194.16 | - | - | - | 128.32 | - | - |
P/E ratio (year end quote) | 194.16 | - | - | - | 128.32 | - | - |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Equity ratio in % | 26.61 | 26.64 | 31.08 | 31.31 | 30.93 | 29.72 | 13.46 |
Debt ratio in % | 73.39 | 73.36 | 68.92 | 68.69 | 69.07 | 70.28 | 83.22 |
Ceridian HCM Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Alkharrat Samer | 06/08/2024 | 11,047.00 | 90,234.00 | 51.53 | Sell | No |
McDonald William Everett | 05/19/2024 | 5,995.00 | 73,385.00 | 63.28 | Sell | No |
McDonald William Everett | 05/19/2024 | 995.00 | 79,380.00 | 44.91 | Buy | No |
McDonald William Everett | 05/19/2024 | 1,250.00 | 78,385.00 | 22.00 | Buy | No |
McDonald William Everett | 05/19/2024 | 3,750.00 | 77,135.00 | 19.04 | Buy | No |
Rosen Andrea | 05/14/2024 | 560.00 | 11,385.00 | 62.60 | Sell | No |
FARRINGTON DEBORAH A | 05/02/2024 | 4,363.00 | 23,230.00 | n/a | Buy | No |
THOMAS H. LEE ADVISORS, LLC | 05/02/2024 | 5,367.00 | 90,745.00 | n/a | Buy | No |
Clarke Ronald | 05/02/2024 | 4,363.00 | 31,669.00 | n/a | Buy | No |
BICKETT BRENT B | 05/02/2024 | 5,454.00 | 18,474.00 | n/a | Buy | No |
Rosen Andrea | 05/02/2024 | 4,363.00 | 11,945.00 | n/a | Buy | No |
Rao Gnaneshwar B. | 05/02/2024 | 5,236.00 | 58,489.00 | n/a | Buy | No |
Mantia Linda Provie | 05/02/2024 | 4,363.00 | 20,480.00 | n/a | Buy | No |
Armstrong Christopher R | 03/21/2024 | 2,474.00 | 149,319.00 | 70.75 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 7,298.00 | 151,793.00 | 70.00 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 40,228.00 | 159,091.00 | 68.88 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 100.00 | 149,319.00 | 70.82 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 1,804.00 | 149,419.00 | 70.18 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 8,096.00 | 151,223.00 | 68.88 | Sell | No |
Armstrong Christopher R | 03/21/2024 | 50,000.00 | 199,319.00 | 44.91 | Buy | No |
McDonald William Everett | 03/07/2024 | 705.00 | 73,159.00 | 66.92 | Sell | No |
McDonald William Everett | 03/07/2024 | 705.00 | 72,320.00 | 66.92 | Sell | No |
Korngiebel Joseph B | 03/07/2024 | 3,131.00 | 151,018.00 | 66.92 | Sell | No |
Korngiebel Joseph B | 03/07/2024 | 3,131.00 | 147,972.00 | 66.92 | Sell | No |
Jacobs Jeffrey Scott | 03/07/2024 | 253.00 | 34,215.00 | 66.92 | Sell | No |
Ceridian HCM Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2022 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2021 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2020 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2019 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2018 | Ceridian HCM Holding Inc Registered Shs | 0.00 | 0.00 | USD |
2017 | Ceridian HCM Holding Inc Registered Shs | - | - | USD |
2016 | Ceridian HCM Holding Inc Registered Shs | - | - | USD |
2015 | Ceridian HCM Holding Inc Registered Shs | - | - | USD |
*Yield of the Respective Date
Ceridian HCM Holding Inc Registered Shs Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 0.363 USD | Q2 2024 Earnings Release | 07/31/2024 |
Earnings Report | 0.414 USD | Q3 2024 Earnings Release | 10/30/2024 |
Earnings Report | 0.428 USD | Q4 2024 Earnings Release | 02/05/2025 |
Earnings Report | 0.522 USD | Q1 2025 Earnings Release | 04/30/2025 |
Earnings Report | 0.441 USD | Q2 2025 Earnings Release | 07/30/2025 |
Ceridian HCM Holding Inc Registered Shs Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Press Conference | - | - | 05/01/2024 |
Annual General Meeting | - | Annual General Meeting | 04/26/2024 |
Ceridian HCM Profile
Dayforce, Inc. engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels. The Bureau solutions offer payroll and payroll-related services using legacy technology. The company was founded in 1992 and is headquartered in Minneapolis, MN. .
Moody’s Daily Credit Risk Score
Ceridian HCM Shareholder
Owner | in % |
---|---|
Freefloat | 98.19 |
T Rowe Price Associates, Inc. (13F Subfiler) | 12.65 |
T. Rowe Price Associates, Inc. (Investment Management) | 12.23 |
Capital Research & Management Co. (International Investors) | 10.85 |
The Vanguard Group, Inc. | 10.65 |
Vanguard Group, Inc. (Subfiler) | 10.37 |
Capital Research & Management Co. (International Investors) | 10.17 |
Capital Research & Management Co. (Global Investors) | 9.87 |
Select Equity Group LP | 9.67 |
Select Equity Group LP | 9.51 |
T Rowe Price New Horizons Fund | 6.75 |
American Funds AMCAP Fund | 6.18 |
Capital Research & Management Co. (World Investors) | 6.00 |
American Funds Fundamental Investors | 5.63 |
Edgepoint Investment Group, Inc. | 5.44 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.